Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru.
about
Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic reviewGenetic diversity of Mycobacterium tuberculosis in Peru and exploration of phylogenetic associations with drug resistanceAssociation between HIV/AIDS and multi-drug resistance tuberculosis: a systematic review and meta-analysisMortality among MDR-TB cases: comparison with drug-susceptible tuberculosis and associated factorsImaging Features of Pulmonary CT in Type 2 Diabetic Patients with Multidrug-Resistant TuberculosisProtocol for studying cough frequency in people with pulmonary tuberculosis.The provision of and need for social support among adult and pediatric patients with tuberculosis in Lima, Peru: a qualitative study.Evaluation of molecular tools for detection and drug susceptibility testing of Mycobacterium tuberculosis in stool specimens from patients with pulmonary tuberculosis.Weight variation over time and its association with tuberculosis treatment outcome: a longitudinal analysis.Initial presentations predict mortality in pulmonary tuberculosis patients--a prospective observational studyImproved diagnosis of pleural tuberculosis using the microscopic- observation drug-susceptibility techniqueFactors associated with delayed tuberculosis test-seeking behavior in the Peruvian Amazon.Discriminating active from latent tuberculosis in patients presenting to community clinics.High Frequency of First-Line Anti-Tuberculosis Drug Resistance among Persons with Chronic Pulmonary Tuberculosis at a Teaching Hospital Chest Clinic.Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study.Patient Reported Delays in Seeking Treatment for Tuberculosis among Adult and Pediatric TB Patients and TB Patients Co-Infected with HIV in Lima, Peru: A Qualitative StudyPredictors of death during tuberculosis treatment in TB/HIV co-infected patients in Malaysia.Averting epidemics of extensively drug-resistant tuberculosisKnowledge about HIV prevention and transmission among recently diagnosed tuberculosis patients: a cross sectional study.GeneXpert--a game-changer for tuberculosis control?Clinical evaluation of tuberculosis viability microscopy for assessing treatment response.Evaluation of Microscopic Observation Drug Susceptibility (MODS) and the string test for rapid diagnosis of pulmonary tuberculosis in HIV/AIDS patients in Bolivia.Prevalence and factors associated with tuberculosis treatment outcome among hazardous or harmful alcohol users in public primary health care in South AfricaProlonged infectiousness of tuberculosis patients in a directly observed therapy short-course program with standardized therapy.Impact of HIV on mortality among patients treated for tuberculosis in Lima, Peru: a prospective cohort studyModeling the dynamic relationship between HIV and the risk of drug-resistant tuberculosis.Community-based rapid oral human immunodeficiency virus testing for tuberculosis patients in Lima, PeruDrug resistance pattern of mycobacterial isolates in HIV and non-HIV population in South IndiaTuberculosis diagnosis and multidrug resistance testing by direct sputum culture in selective broth without decontamination or centrifugation.Mycobacterial Etiology of Pulmonary Tuberculosis and Association with HIV Infection and Multidrug Resistance in Northern NigeriaThe transmission and control of XDR TB in South Africa: an operations research and mathematical modelling approach.Is Multi-Drug Resistant Tuberculosis More Prevalent in HIV-Infected Patients in Korea?Novel relationship between tuberculosis immune reconstitution inflammatory syndrome and antitubercular drug resistanceEvaluation of GeneXpert MTB/RIF assay for direct diagnosis of pulmonary tuberculosis.Detecting Mutations in the Mycobacterium tuberculosis Pyrazinamidase Gene pncA to Improve Infection Control and Decrease Drug Resistance Rates in Human Immunodeficiency Virus Coinfection.Impact of Infection Control Measures to Control an Outbreak of Multidrug-Resistant Tuberculosis in a Human Immunodeficiency Virus Ward, PeruComparison of sputum collection methods for tuberculosis diagnosis: a systematic review and pairwise and network meta-analysis.Sputum microscopy with fluorescein diacetate predicts tuberculosis infectiousness.Why wait? The social determinants underlying tuberculosis diagnostic delay.
P2860
Q28475509-23A9E793-B8E0-4ED5-9853-711C5387DDD3Q28534210-7FAC3C85-8614-414B-8E3B-92888B6C1AACQ28538427-22756DB8-4F07-4D6A-83AE-F67F8626802EQ28544684-021A9D76-21D0-4325-9B55-D61C2D7D72EFQ28551035-8C8D2235-E080-4AC5-A615-D8BD7E32C9ABQ28603361-72E5C8B3-E1E2-4690-A2C0-9CF24A435A12Q31125407-ACCD2B01-6623-4832-BBA5-CAD9D5B95BC9Q33827194-7C555A0F-F82D-465B-929B-3EC31225DFA3Q33873562-C5647C4A-4956-4908-B1C1-56F6D8DEB4C9Q34023140-977CC266-2501-4DE3-AF4D-DC75D7F6BC51Q34029928-7DB716E1-1B6D-4380-AFC0-5C8912DD0A22Q34029942-C0046C6D-4889-45A6-8B04-DDDEF75D5855Q34292798-E39257DC-21F8-40F8-86E7-044A4CD12844Q34363124-8425E2E1-A5E6-4D90-9EBE-6AB13E67278DQ34707237-57614F32-16A6-4EDB-BBA5-EE9E115DE3F8Q34755533-854E601E-7119-4786-9E82-7A6BE8B3CBAAQ34951938-5CF29128-E8E1-4B90-9BCE-BB037F8996E5Q34975537-E8D8F254-882D-413B-AC39-AD20722FC197Q35077011-EE46E531-B013-4DEF-817F-A1D7F4FEC791Q35129500-19716EF7-C3DD-4DF9-8327-C89863BAAA4EQ35207458-C6106414-729F-4150-BE65-559311CA06DDQ35654885-8811CA82-EB90-4BF7-8E5D-E5EBD6E201ECQ35665143-D36BE0B7-86ED-410B-A04B-79D2C6437928Q35736494-63249C06-A910-4A67-99D6-917944F908A8Q35910430-C031DBC1-A1BE-48A4-B709-87A1C0EE0518Q36070976-C7B216C8-DC76-4848-A5BF-8D6D5F592EFBQ36213203-4A74C01B-DCD5-49DF-93E7-31858B465CA3Q36566188-92C372C2-F8A7-4AF8-BC47-E162A710C34FQ36747642-B48441B8-3CEA-47B5-A573-E5EF3FFB32E7Q37061276-790BBEF7-E331-4E9F-8844-A3D3F7506449Q37208930-3D60EF46-D695-4C98-9DE7-BD0C45E77DD5Q37231921-4B163CC7-1301-4D4B-A105-5C7DFC42E151Q37331456-36EF926E-D1E2-4E15-9897-3EA85AFB64ACQ37359228-0920C325-E2D9-47EE-94B7-754FC10148C4Q37499482-DAC72FF7-F7DF-43E2-8C01-E99C8D9EBEC5Q37499488-409D7ADA-6840-4BB6-9CE0-E18DD6348A0EQ38720366-ABECF025-3E55-4E27-9E4A-0FC9DBE15C81Q40210450-3DE05D0A-99E1-429D-9B58-8DB35F52D555Q41930732-2501E7E8-30C5-4DDA-8034-90191D150EF9
P2860
Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru.
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Tuberculosis mortality, drug r ...... without HIV infection in Peru.
@ast
Tuberculosis mortality, drug r ...... without HIV infection in Peru.
@en
Tuberculosis mortality, drug r ...... without HIV infection in Peru.
@nl
type
label
Tuberculosis mortality, drug r ...... without HIV infection in Peru.
@ast
Tuberculosis mortality, drug r ...... without HIV infection in Peru.
@en
Tuberculosis mortality, drug r ...... without HIV infection in Peru.
@nl
prefLabel
Tuberculosis mortality, drug r ...... without HIV infection in Peru.
@ast
Tuberculosis mortality, drug r ...... without HIV infection in Peru.
@en
Tuberculosis mortality, drug r ...... without HIV infection in Peru.
@nl
P2093
P2860
P1476
Tuberculosis mortality, drug r ...... without HIV infection in Peru.
@en
P2093
A Roderick Escombe
Christian T Bautista
Eduardo Ticona
Giselle Soto
Jaime Ortiz
Luz Caviedes
Luz Huaroto
Marco Tovar
Richard Rodriguez
Victor Chavez
P2860
P304
P407
P577
2006-12-01T00:00:00Z